Log in to save to my catalogue

Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective th...

Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e40f3105af14974bb2c5361fb6ece02

Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer

About this item

Full title

Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-03, Vol.12 (1), p.4028-4028, Article 4028

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Human triosephosphate isomerase (HsTIM) is a central glycolytic enzyme and is overexpressed in cancer cells with accelerated glycolysis. Triple-negative breast cancer is highly dependent on glycolysis and is typically treated with a combination of surgery, radiation therapy, and chemotherapy. Deamidated HsTIM was recently proposed as a druggable ta...

Alternative Titles

Full title

Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8e40f3105af14974bb2c5361fb6ece02

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e40f3105af14974bb2c5361fb6ece02

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-08051-0

How to access this item